Your browser doesn't support javascript.
loading
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial.
Pizzuti, Laura; Barba, Maddalena; Mazzotta, Marco; Krasniqi, Eriseld; Maugeri-Saccà, Marcello; Gamucci, Teresa; Berardi, Rossana; Livi, Lorenzo; Ficorella, Corrado; Natoli, Clara; Cortesi, Enrico; Generali, Daniele; La Verde, Nicla; Cassano, Alessandra; Bria, Emilio; Moscetti, Luca; Michelotti, Andrea; Adamo, Vincenzo; Zamagni, Claudio; Tonini, Giuseppe; Sergi, Domenico; Marinelli, Daniele; Paoletti, Giancarlo; Tomao, Silverio; Botticelli, Andrea; Marchetti, Paolo; Tinari, Nicola; Grassadonia, Antonino; Valerio, Maria Rosaria; Mirabelli, Rosanna; Fabbri, Maria Agnese; D'Ostilio, Nicola; Veltri, Enzo; Corsi, Domenico; Garrone, Ornella; Paris, Ida; Sarobba, Giuseppina; Meattini, Icro; Pistelli, Mirco; Giotta, Francesco; Lorusso, Vito; Garufi, Carlo; Russo, Antonio; Cazzaniga, Marina; Del Medico, Pietro; Roselli, Mario; Vaccaro, Angela; Perracchio, Letizia; di Benedetto, Anna; Daralioti, Theodora.
Afiliación
  • Pizzuti L; Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.
  • Barba M; Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.
  • Mazzotta M; Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy. marcomazzotta88@gmail.com.
  • Krasniqi E; Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.
  • Maugeri-Saccà M; Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.
  • Gamucci T; Medical Oncology, Sandro Pertini Hospital, Rome, Italy.
  • Berardi R; Oncology Clinic, Ospedali Riuniti Di Ancona, Università Politecnica Delle Marche, Ancona, Italy.
  • Livi L; Radiation Oncology, Department of Experimental and Clinical Biomedical Sciences, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Florence, Italy.
  • Ficorella C; Medical Oncology, Department of Biotechnological and Applied Clinical Sciences, St. Salvatore Hospital, University of L'Aquila, L'Aquila, Italy.
  • Natoli C; Department of Medical, Oral and Biotechnological Sciences, University G. D'Annunzio, Chieti-Pescara, Italy.
  • Cortesi E; Medical Oncology Unit B, Policlinico Umberto I, Department of Radiological, Oncological and Pathological Sciences, Sapienza - Università di Roma, Rome, Italy.
  • Generali D; Breast Cancer Unit, ASST Cremona, Cremona, Italy.
  • La Verde N; Oncology Unit, ASST Fatebenefratelli Sacco Presidio Ospedaliero Fatebenefratelli, Milan, Italy.
  • Cassano A; U.O.C. Medical Oncology, Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Bria E; U.O.C. Medical Oncology, Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Moscetti L; Division of Medical Oncology, Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy.
  • Michelotti A; UO Medical Oncology I, Transplant and New Technologies Department, S. Chiara Hospital, Oncology, Pisa University Hospital, Pisa, Italy.
  • Adamo V; Medical Oncology Unit, A.O. Papardo, Department Human Pathology, University of Messina, Messina, Italy.
  • Zamagni C; Medical Oncology Unit, S.Orsola-Malpighi Hospital, Bologna, Italy.
  • Tonini G; Department of Oncology, University Campus Biomedico of Rome, Rome, Italy.
  • Sergi D; Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.
  • Marinelli D; Medical Oncology Unit, Department of Clinical and Molecular Medicine, Sant'Andrea University Hospital, Sapienza Università di Roma, Rome, Italy.
  • Paoletti G; Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.
  • Tomao S; Medical Oncology Unit A, Policlinico Umberto I, Department of Radiological, Oncological and Pathological Sciences, Sapienza - Università di Roma, Rome, Italy.
  • Botticelli A; Medical Oncology Unit B, Policlinico Umberto I, Department of Radiological, Oncological and Pathological Sciences, Sapienza - Università di Roma, Rome, Italy.
  • Marchetti P; Medical Oncology Unit B, Policlinico Umberto I, Department of Radiological, Oncological and Pathological Sciences, Sapienza - Università di Roma, Rome, Italy.
  • Tinari N; Medical Oncology Unit, Department of Clinical and Molecular Medicine, Sant'Andrea University Hospital, Sapienza Università di Roma, Rome, Italy.
  • Grassadonia A; Department of Medical, Oral and Biotechnological Sciences, University G. D'Annunzio, Chieti-Pescara, Italy.
  • Valerio MR; Department of Medical, Oral and Biotechnological Sciences, University G. D'Annunzio, Chieti-Pescara, Italy.
  • Mirabelli R; Medical Oncology Unit, AOU Policlinico Paolo Giaccone, Palermo, Italy.
  • Fabbri MA; Department of Ematology and Oncology, Pugliese-Ciaccio Hospital, Catanzaro, Italy.
  • D'Ostilio N; Medical Oncology Unit, Belcolle Hospital, Viterbo, Italy.
  • Veltri E; Medical Oncology Unit, Lanciano-Vasto, Italy.
  • Corsi D; Medical Oncology Unit, Santa Maria Goretti, Latina, Italy.
  • Garrone O; Medical Oncology Unit, San Giovanni Calibita Fatebenefratelli Hospital, Rome, Italy.
  • Paris I; Medical Oncology Unit, AO S. Croce and Carle Teaching Hospital, Cuneo, Italy.
  • Sarobba G; Division of Gynecologic Oncology, Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Meattini I; Department of Medical Oncology, ASL Nuoro, Nuoro, Italy.
  • Pistelli M; Radiation Oncology, Department of Experimental and Clinical Biomedical Sciences, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Florence, Italy.
  • Giotta F; Oncology Clinic, Ospedali Riuniti Di Ancona, Università Politecnica Delle Marche, Ancona, Italy.
  • Lorusso V; Department of Medical Oncology, IRCCS Giovanni Paolo II Institute, Bari, Italy.
  • Garufi C; Department of Medical Oncology, IRCCS Giovanni Paolo II Institute, Bari, Italy.
  • Russo A; Division of Medical Oncology, San Camillo Forlanini Hospital, Roma, Italy.
  • Cazzaniga M; Medical Oncology Unit, AOU Policlinico Paolo Giaccone, Palermo, Italy.
  • Del Medico P; Research Unit Phase I Trials and Oncology Unit, ASST Monza, Monza, Italy.
  • Roselli M; Division of Medical Oncology, Reggio Calabria General Hospital, Reggio Calabria, Italy.
  • Vaccaro A; Department of Systems Medicine, Medical Oncology, University of Rome Tor Vergata, Rome, Italy.
  • Perracchio L; Medical Oncology Unit, ASL Frosinone, Frosinone, Italy.
  • di Benedetto A; Pathology Department, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Daralioti T; Pathology Department, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Sci Rep ; 11(1): 13770, 2021 07 02.
Article en En | MEDLINE | ID: mdl-34215766
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pronóstico / Neoplasias Encefálicas / Neoplasias de la Mama / Receptor ErbB-2 Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Sci Rep Año: 2021 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pronóstico / Neoplasias Encefálicas / Neoplasias de la Mama / Receptor ErbB-2 Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Sci Rep Año: 2021 Tipo del documento: Article País de afiliación: Italia